Skip to content
Inciteful Med

Biology and Types of Hemoglobin C

Last updated:

Hemoglobin C is an inherited blood condition caused by a genetic mutation. Having one Hemoglobin C gene (HbAC trait) causes no symptoms, while inheriting two (HbCC) causes mild anemia. Inheriting it alongside a sickle cell gene causes HbSC, a form of sickle cell disease.

Key Takeaways

  • • Hemoglobin C is caused by a genetic mutation that replaces glutamic acid with lysine in the hemoglobin protein.
  • • The mutation dehydrates red blood cells, causing them to look like bullseyes (target cells) and sometimes form rod-shaped crystals.
  • • Having the Hemoglobin C trait (HbAC) is asymptomatic and provides some natural protection against severe malaria.
  • • Inheriting two Hemoglobin C genes causes HbCC disease, resulting in mild anemia and faster red blood cell breakdown.
  • • Inheriting one Hemoglobin C gene and one Hemoglobin S gene results in HbSC, which is a moderate to severe form of sickle cell disease.

Understanding the biology of Hemoglobin C starts at the microscopic level. Small changes in your genetic code can change the very shape and behavior of your blood, leading to the different “types” or genotypes of the condition.

The Genetic “Glitch”

Hemoglobin is the protein in red blood cells that carries oxygen. It is made of four parts, including two beta-globin chains [1]. Think of your DNA like an instruction manual. Hemoglobin C occurs because of a single, specific “typo” in the instructions that build these chains.

In a normal gene, the 6th “letter” (amino acid) in the chain is glutamic acid. In Hemoglobin C, this is replaced by lysine [2]. This might seem like a tiny change, but it radically alters the electrical charge of the hemoglobin molecule [3][4]. This new version is called β\betaE6K [2].

What Happens to the Red Blood Cell?

Because of this charge change, Hemoglobin C does not dissolve as easily in the fluid inside the cell. This leads to three main physical changes:

  • Crystallization: The hemoglobin molecules can clump together to form microscopic, rod-shaped crystals [5][6].
  • Dehydration (Xerocytosis): The mutation causes the cell membrane to leak potassium and water [7][8]. This makes the cell “thirsty” and shriveled, a state called xerocytosis [9].
  • Target Cells: Because the cells are dehydrated and have a different internal structure, they often look like bullseyes under a microscope. Doctors call these target cells or codocytes [10][11].

The Genotype Matrix

How the condition affects you depends entirely on which genes you inherited from your parents.

1. HbAC (Hemoglobin C Trait)

  • Inheritance: One Hemoglobin C gene and one normal Hemoglobin A gene [2].
  • Severity: Asymptomatic. This is not a disease; it is a “carrier” status.
  • Key Fact: People with HbAC trait often have a natural protection against severe malaria [2][12].

2. HbCC (Hemoglobin C Disease)

  • Inheritance: Two Hemoglobin C genes (one from each parent) [13].
  • Severity: Mild. It causes mild hemolysis (faster breakdown of red blood cells) and mild anemia [13][14]. HbCC is not sickle cell disease.
  • Visuals: Blood smears often show many target cells and occasional rod-shaped crystals [5][10].

3. HbSC (Hemoglobin SC Disease)

  • Inheritance: One Hemoglobin S (sickle) gene and one Hemoglobin C gene [15].
  • Severity: Moderate to Severe. This is a form of Sickle Cell Disease [15][16].
  • Biological Difference: The Hemoglobin C makes the Hemoglobin S “sickle” more easily by dehydrating the cell [17]. While often considered “milder” than the most severe form of sickle cell (HbSS), HbSC can still cause significant health issues like eye damage (retinopathy) and spleen complications [17][18].

How It Is Inherited

Hemoglobin C follows a Mendelian inheritance pattern. This means it is passed down predictably. If both parents have the HbAC trait, for each pregnancy there is a:

  • 25% chance the child will have normal hemoglobin (HbAA).
  • 50% chance the child will have the trait (HbAC).
  • 25% chance the child will have the disease (HbCC).

If one parent has the Sickle Cell Trait (HbAS) and the other has the Hemoglobin C Trait (HbAC), there is a 25% chance with each pregnancy that the child will have HbSC disease [19].

Frequently Asked Questions

What is the difference between Hemoglobin C trait and Hemoglobin C disease?
Hemoglobin C trait (HbAC) means you carry one mutated gene and one normal gene, which causes no symptoms. Hemoglobin C disease (HbCC) means you inherited two mutated genes, which can cause mild anemia and a faster breakdown of your red blood cells.
Is Hemoglobin C the same as sickle cell disease?
Hemoglobin C disease (HbCC) is not sickle cell disease and is usually mild. However, if you inherit one Hemoglobin C gene and one sickle cell gene, it results in Hemoglobin SC (HbSC) disease, which is a moderate to severe form of sickle cell disease.
How does Hemoglobin C change red blood cells?
The genetic mutation changes the electrical charge of the hemoglobin protein. This causes the red blood cells to become dehydrated and shrink, often making them look like bullseyes under a microscope and sometimes causing the hemoglobin to form rod-shaped crystals.
If I have the Hemoglobin C trait, will I pass it to my children?
Yes, Hemoglobin C is predictably passed down from parents to children. For example, if both parents have the Hemoglobin C trait, there is a 25 percent chance with each pregnancy that their child will have Hemoglobin C disease.

Questions for Your Doctor

  • • Based on my specific genotype (HbCC, HbAC, or HbSC), what are the most important complications I should be monitoring?
  • • Since I have the Hemoglobin C gene, should my partner be tested before we have children to determine the exact risks?
  • • What percentage of my hemoglobin is Hemoglobin C versus Hemoglobin A or S?
  • • How does the 'dehydration' of my red blood cells affect my risk for things like blood clots or eye issues?

Questions for You

  • • Do I know the specific hemoglobin status of my biological parents (e.g., do they have 'the trait')?
  • • Have I discussed inheritance risks with my family or a genetic counselor?
  • • What specific symptoms, like unusual fatigue or bone pain, have I experienced that might relate to my genotype?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Genome-wide association study of erythrocyte density in sickle cell disease patients.

    Ilboudo Y, Bartolucci P, Rivera A, et al.

    Blood cells, molecules & diseases 2017; (65()):60-65 doi:10.1016/j.bcmd.2017.05.005.

    PMID: 28552477
  2. 2

    Hemoglobin Genotypes Modulate Inflammatory Response to Plasmodium Infection.

    Harp KO, Botchway F, Dei-Adomakoh Y, et al.

    Frontiers in immunology 2020; (11()):593546 doi:10.3389/fimmu.2020.593546.

    PMID: 33424841
  3. 3

    Epidermolysis bullosa simplex-generalized severe type due to keratin 5 p.Glu477Lys mutation: Genotype-phenotype correlation and in silico modeling analysis.

    Lalor L, Titeux M, Palisson F, et al.

    Pediatric dermatology 2019; (36(1)):132-138 doi:10.1111/pde.13722.

    PMID: 30515866
  4. 4

    6-Phosphogluconate dehydrogenase 2 bridges the OPP and shikimate pathways to enhance aromatic amino acid production in plants.

    Tang Q, Huang Y, Shen Z, et al.

    Science China. Life sciences 2024; (67(11)):2488-2498 doi:10.1007/s11427-024-2567-4.

    PMID: 39060614
  5. 5

    Rod-Shaped Hemoglobin Crystals: Clues to the Diagnosis of Hemoglobin C Disease.

    Xu K, Zhao J, Dramé BSI, et al.

    Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2024; (40(2)):368-369 doi:10.1007/s12288-023-01713-7.

    PMID: 38708168
  6. 6

    Hemoglobin C Disease With Splenomegaly and With Factor II Mutation Gene Thrombophilia: A Case Report.

    Vázquez-Folch SJ, Jiménez-Berríos GA, Izquierdo N, Vazquez VJ

    Cureus 2025; (17(9)):e91937 doi:10.7759/cureus.91937.

    PMID: 41080369
  7. 7

    The Effect of Antioxidants on the Properties of Red Blood Cells From Patients With Sickle Cell Anemia.

    Al Balushi H, Hannemann A, Rees D, et al.

    Frontiers in physiology 2019; (10()):976 doi:10.3389/fphys.2019.00976.

    PMID: 31456691
  8. 8

    Sickle cell dehydration: Pathophysiology and therapeutic applications.

    Brugnara C

    Clinical hemorheology and microcirculation 2018; (68(2-3)):187-204 doi:10.3233/CH-189007.

    PMID: 29614632
  9. 9

    Herbal Drug use in Sickle Cell Disease Management; Trends and Perspectives in Sub-Saharan Africa - A Systematic Review.

    Okoh MP, Alli LA, Tolvanen MEE, Nwegbu MM

    Current drug discovery technologies 2019; (16(4)):372-385 doi:10.2174/1570163815666181002101611.

    PMID: 30277160
  10. 10

    Hemoglobinosis C in Morocco : A report of 111 cas.

    Ouzzif Z, El Maataoui A, Oukhedda N, et al.

    La Tunisie medicale 2017; (95(12)):229-233.

    PMID: 29878289
  11. 11

    An incidental finding of a hemoglobin E variant in a diabetic patient with an abnormal glycated hemoglobin level: a case report.

    Karki R, Lamichhane S, Jha R, Manandhar R

    Journal of medical case reports 2024; (18(1)):279 doi:10.1186/s13256-024-04518-y.

    PMID: 38877536
  12. 12

    Hemoglobin C Trait Provides Protection From Clinical Falciparum Malaria in Malian Children.

    Travassos MA, Coulibaly D, Laurens MB, et al.

    The Journal of infectious diseases 2015; (212(11)):1778-86 doi:10.1093/infdis/jiv308.

    PMID: 26019283
  13. 13

    Hemoglobin C Disorder in Anemic Patients Referred to the National Center for Thalassemia and Genetic Counseling in Damascus.

    Ahmad A, Fattoum K, Imam W, et al.

    International journal of hematology-oncology and stem cell research 2024; (18(2)):183-191 doi:10.18502/ijhoscr.v18i2.15376.

    PMID: 38868813
  14. 14

    [Diagnosis of non-autoimmune hemolysis in the adult].

    Ruivard M, Michel M, Garçon L

    La Revue de medecine interne 2025; (46(12)):725-732 doi:10.1016/j.revmed.2025.08.001.

    PMID: 40930929
  15. 15

    Atypical Overt Hemorrhagic Stroke in an Adult With Sickle Cell-Hemoglobin C Disease: A Report of a Rare Case.

    Manjrekar NS, Preisig AM, Singh C, Rezwan M

    Cureus 2026; (18(1)):e100573 doi:10.7759/cureus.100573.

    PMID: 41625049
  16. 16

    Gene therapy for HbSC disease and other compound heterozygous sickle hemoglobinopathies: a time for inclusion.

    Wilks A, Steinberg MH, Frangoul H

    Blood 2025; (146(20)):2385-2391 doi:10.1182/blood.2025029964.

    PMID: 40834880
  17. 17

    A novel mouse model of hemoglobin SC disease reveals mechanisms underlying beneficial effects of hydroxyurea.

    Setayesh T, Chi M, Oestreicher Z, et al.

    Blood 2025; (146(1)):13-28 doi:10.1182/blood.2024028136.

    PMID: 40324066
  18. 18

    Uncommon Presentation of Hypersplenism in Adult Sickle Cell Disease Patients: A Rare Case Report.

    Qureshi A, Kasbawala K, Santos MT, et al.

    The American journal of case reports 2024; (25()):e944693 doi:10.12659/AJCR.944693.

    PMID: 39300742
  19. 19

    Thrombosis risk with haemoglobin C trait and haemoglobin C disease: A systematic review.

    Jacobs JW, Sharma D, Stephens LD, et al.

    British journal of haematology 2024; (204(4)):1500-1506 doi:10.1111/bjh.19313.

    PMID: 38291731

This page explains the biology and genetics of Hemoglobin C for educational purposes. Always consult your hematologist or a genetic counselor to discuss your specific genotype, inheritance risks, and necessary monitoring.

Stay up to date

Get notified when new research about Hemoglobin C disease is published.

No spam. Unsubscribe anytime.